A medical oncology registrar, Dr. Greg Korpanty, working with Dr. Bryan Hennessy has just recently won a prestigious merit award from the American Society of Clinical Oncology (ASCO) that will be presented to him at the annual meeting of ASCO in June in Chicago. The award was given for a research project entitled ‘Loss of heterozygosity (LOH) as a measure of whole genome instability in ovarian cancer correlates with clinical outcomes’.
This research will also be highlighted by an expert discussant at the annual meeting in Chicago as one of the outstanding research abstracts submitted to ASCO this year.